Barinthus Biotherapeutics Plc (BRNS)
0.7401
-0.02
(-2.49%)
USD |
NASDAQ |
Sep 08, 16:00
0.7628
+0.02
(+3.07%)
After-Hours: 20:00
Barinthus Biotherapeutics Debt to Equity Ratio : 0.1804 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1804 |
| March 31, 2026 | 0.1658 |
| December 31, 2025 | 0.152 |
| September 30, 2025 | 0.137 |
| June 30, 2025 | 0.1171 |
| March 31, 2025 | 0.1032 |
| December 31, 2024 | 0.0923 |
| September 30, 2024 | 0.0795 |
| June 30, 2024 | 0.0803 |
| March 31, 2024 | 0.0745 |
| December 31, 2023 | 0.0695 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.065 |
| June 30, 2023 | 0.0561 |
| March 31, 2023 | 0.0457 |
| December 31, 2022 | 0.0361 |
| September 30, 2022 | 0.0339 |
| June 30, 2022 | 0.0339 |
| March 31, 2022 | 0.0266 |
| September 30, 2021 | 0.0337 |
| June 30, 2021 | 0.0064 |
| March 31, 2021 | 0.0105 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.89M |
| Total Liabilities (Quarterly) | 24.76M |
| Shareholders Equity (Quarterly) | 57.07M |
| Current Ratio | 5.539 |
| Net Debt Paydown Yield | 1.20% |